BNP Paribas Call 80 NOVN 20.09.20.../ DE000PZ1AZP4 /
| 2024-05-03 4:21:07 PM | Chg.-0.060 | Bid5:16:55 PM | Ask5:16:55 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.980EUR | -5.77% | - Bid Size: - |
- Ask Size: - |
NOVARTIS N | 80.00 CHF | 2024-09-20 | Call |
GlobeNewswire
04-16
Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthriti...
GlobeNewswire
03-14
IgA Nephropathy Pipeline Dynamics Signal Further Treatment Evolution on the Horizon
GlobeNewswire
02-28
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
GlobeNewswire
01-10
Novartis' Cosentyx Shows Promising Early Progress in Treating Hidradenitis Suppurativa, Poised for S...
GlobeNewswire
01-05
Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand ...
GlobeNewswire
01-02
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Ad...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-19
Related Sciences Adds 8 New Senior Advisors Including Former CEOs and Heads of R&D from Genentech, N...
GlobeNewswire
2023-12-11
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and ...
GlobeNewswire
2023-12-08
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broa...
GlobeNewswire
2023-12-06
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement i...
GlobeNewswire
2023-11-20
Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH
GlobeNewswire
2023-10-19
Fairway Consulting Group Appoints Matthew Perry as Vice President of Executive Search
GlobeNewswire
2023-10-10
Olema Oncology Announces Expansion of Collaboration Agreement with Novartis
